Stockreport

Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET [Yahoo! Finance]

Bicara Therapeutics Inc.  (BCAX) 
PDF company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it will report fourth quarter and full year 2025 [Read more]